• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PRAME positive spiradenocarcinoma treated with Mohs micrographic surgery.

作者信息

Miller Austinn C, Acosta-Peñaloza John S, Constantinescu Monica, Schaffer András, Cognetta Armand B

机构信息

Dermatology Associates of Tallahassee, Tallahassee, Florida.

University of Central Florida/HCA Healthcare Consortium, Tallahassee, Florida.

出版信息

JAAD Case Rep. 2025 Feb 17;59:22-25. doi: 10.1016/j.jdcr.2025.01.022. eCollection 2025 May.

DOI:10.1016/j.jdcr.2025.01.022
PMID:40225093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11992405/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/3fd016c6fda9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/258f6e920c29/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/8458d87811c5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/3fd016c6fda9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/258f6e920c29/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/8458d87811c5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a3/11992405/3fd016c6fda9/gr3.jpg

相似文献

1
PRAME positive spiradenocarcinoma treated with Mohs micrographic surgery.采用莫氏显微外科手术治疗的PRAME阳性汗腺癌
JAAD Case Rep. 2025 Feb 17;59:22-25. doi: 10.1016/j.jdcr.2025.01.022. eCollection 2025 May.
2
Spiradenocarcinoma of the scalp.头皮汗腺癌
Cutis. 2002 Jun;69(6):455-8.
3
Spiradenocarcinoma Treated With Mohs Micrographic Surgery.用莫氏显微外科手术治疗的汗腺癌
Dermatol Surg. 2019 Jan;45(1):152-154. doi: 10.1097/DSS.0000000000001534.
4
Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases.用莫氏显微外科手术治疗的小汗腺癌：5例报告
Dermatol Surg. 1999 Nov;25(11):911-3. doi: 10.1046/j.1524-4725.1999.99121.x.
5
Mohs micrographic surgery for squamoid eccrine ductal carcinoma.莫氏显微外科手术治疗鳞状小汗腺导管癌。
Dermatol Surg. 2005 Nov;31(11 Pt 1):1462-4. doi: 10.2310/6350.2005.31219.
6
Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.在评估恶性雀斑样痣和恶性雀斑样痣黑素瘤的慢切组织边缘时，PRAME 和 Melan A 的双重免疫组织化学标记。
Br J Biomed Sci. 2024 Mar 19;81:12319. doi: 10.3389/bjbs.2024.12319. eCollection 2024.
7
[Malignant transformation of an eccrine spiradenoma].[小汗腺螺旋腺瘤的恶性转化]
Ann Dermatol Venereol. 2017 Mar;144(3):203-207. doi: 10.1016/j.annder.2016.09.038. Epub 2016 Oct 27.
8
Infiltrative recurrent eccrine spiradenoma of the anterior neck treated using Mohs micrographic surgery.采用莫氏显微外科手术治疗的颈部前方浸润性复发性小汗腺螺旋腺瘤
Dermatol Surg. 2013 Nov;39(11):1711-4. doi: 10.1111/dsu.12328. Epub 2013 Oct 1.
9
Mohs micrographic surgery in the setting of squamoid eccrine ductal carcinoma: addressing a diagnostic and therapeutic challenge.莫氏显微外科手术治疗鳞状小汗腺导管癌：应对诊断和治疗挑战
J Clin Aesthet Dermatol. 2013 Apr;6(4):33-6.
10
Zosteriform spiradenoma with spiradenocarcinoma: A rare entity.伴有汗腺癌的带状汗腺腺瘤：一种罕见的实体。
Indian Dermatol Online J. 2015 Dec;6(Suppl 1):S30-2. doi: 10.4103/2229-5178.171057.

本文引用的文献

1
PRAME Staining of Adnexal Lesions and Common Skin Cancer Types: Biomarker with Potential Diagnostic Utility.附件病变和常见皮肤癌类型的PRAME染色：具有潜在诊断效用的生物标志物
Dermatopathology (Basel). 2024 Dec 12;11(4):364-373. doi: 10.3390/dermatopathology11040039.
2
Enhanced Disease-Specific Survival Among Individuals With Malignant Adnexal Tumors of the Skin Treated With Mohs Surgery: A National Database Study.莫氏手术治疗皮肤恶性附属器肿瘤患者的疾病特异性生存率提高：一项全国性数据库研究
Dermatol Surg. 2025 Jan 1;51(1):11-16. doi: 10.1097/DSS.0000000000004397. Epub 2024 Sep 11.
3
Spiradenocarcinoma: SEER Study of Epidemiology, Survival, and Treatment Options.
汗腺癌：监测、流行病学和最终结果（SEER）研究中的流行病学、生存率及治疗选择
J Clin Med. 2023 Mar 4;12(5):2045. doi: 10.3390/jcm12052045.
4
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition.采用PD-1抑制治疗的转移性汗腺癌
J Natl Compr Canc Netw. 2022 Feb 23:1-3. doi: 10.6004/jnccn.2021.7119.
5
Malignant Eccrine Adenoma With Sarcomatous (Heterologous) Components: Report of a Rare Skin Adnexal Neoplasm With Literature Review.伴有肉瘤样（异源性）成分的恶性小汗腺腺瘤：一例罕见皮肤附属器肿瘤的报告及文献复习
Cureus. 2020 Dec 30;12(12):e12390. doi: 10.7759/cureus.12390.
6
ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.ALK1 热点突变作为人类汗腺瘤和汗管癌的驱动因素。
Nat Commun. 2019 May 17;10(1):2213. doi: 10.1038/s41467-019-09979-0.
7
Spiradenocarcinoma: A Comprehensive Data Review.汗腺癌：全面的数据综述。
Am J Dermatopathol. 2017 Oct;39(10):715-725. doi: 10.1097/DAD.0000000000000910.
8
Locally Advanced Spiroadenocarcinoma in the Regional Axilla of a Breast Cancer Patient: Hallmarks of Definitive Diagnosis and Management.乳腺癌患者腋窝局部晚期汗腺癌：明确诊断与治疗的特征
Rare Tumors. 2015 Sep 7;7(3):5912. doi: 10.4081/rt.2015.5912.
9
A rare case of multiple segmental eccrine spiradenomas.一例罕见的多节段性小汗腺螺旋腺瘤。
J Clin Aesthet Dermatol. 2011 Apr;4(4):38-44.
10
Malignant eccrine spiradenoma.恶性小汗腺螺旋腺瘤
Arch Pathol Lab Med. 2002 May;126(5):591-4. doi: 10.5858/2002-126-0591-MES.